These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 32031119)

  • 1. The role of tumor budding in colorectal adenocarcinoma: Possible involvement of the intestinal cancer stem cell marker Lgr5.
    Sadek SA; A Rehim DM; Fatima S
    Indian J Pathol Microbiol; 2020; 63(1):32-37. PubMed ID: 32031119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lgr5 over-expression is positively related to the tumor progression and HER2 expression in stage pTNM IV colorectal cancer.
    Gao FJ; Chen JY; Wu HY; Shi J; Chen M; Fan XS; Huang Q
    Int J Clin Exp Pathol; 2014; 7(4):1572-9. PubMed ID: 24817953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Lgr5, a marker of intestinal stem cells, in colorectal cancer and its clinicopathological significance.
    He S; Zhou H; Zhu X; Hu S; Fei M; Wan D; Gu W; Yang X; Shi D; Zhou J; Zhou J; Zhu Z; Wang L; Li D; Zhang Y
    Biomed Pharmacother; 2014 Jun; 68(5):507-13. PubMed ID: 24751002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of clinicopathological features and LGR5 expression in colon adenocarcinoma.
    Sato K; Uehara T; Iwaya M; Nakajima T; Miyagawa Y; Ota H; Tanaka E
    Ann Diagn Pathol; 2020 Oct; 48():151587. PubMed ID: 32829068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the adenocarcinoma-associated gene AGR2 and the intestinal stem cell marker LGR5 as biomarkers in colorectal cancer.
    Valladares-Ayerbes M; Blanco-Calvo M; Reboredo M; Lorenzo-Patiño MJ; Iglesias-Díaz P; Haz M; Díaz-Prado S; Medina V; Santamarina I; Pértega S; Figueroa A; Antón-Aparicio LM
    Int J Mol Sci; 2012; 13(4):4367-4387. PubMed ID: 22605983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal stem cell marker LGR5 expression during gastric carcinogenesis.
    Zheng ZX; Sun Y; Bu ZD; Zhang LH; Li ZY; Wu AW; Wu XJ; Wang XH; Cheng XJ; Xing XF; Du H; Ji JF
    World J Gastroenterol; 2013 Dec; 19(46):8714-21. PubMed ID: 24379591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leucine-rich repeat-containing G protein-coupled receptor 5 expression in lymph node metastases of colorectal cancer: Clinicopathological insights and prognostic implications.
    Sawaguchi H; Uehara T; Iwaya M; Asaka S; Nakajima T; Kamakura M; Nagaya T; Yoshizawa T; Ota H; Umemura T
    Pathol Int; 2024 Jul; 74(7):387-393. PubMed ID: 38787285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of leucine-rich repeat-containing G-protein (Lgr5) and its impact on clinicopathological features of colorectal cancer.
    Gzil A; Zarębska I; Jaworski D; Antosik P; Durślewicz J; Maciejewska J; Domanowska E; Skoczylas-Makowska N; Ahmadi N; Grzanka D; Szylberg Ł
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2547-2557. PubMed ID: 32671503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse correlation between PD-L1 expression and LGR5 expression in tumor budding of stage II/III colorectal cancer.
    Sato K; Uehara T; Nakajima T; Iwaya M; Miyagawa Y; Watanabe T; Ota H
    Ann Diagn Pathol; 2021 Jun; 52():151739. PubMed ID: 33862415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
    Stanisavljević L; Myklebust MP; Leh S; Dahl O
    Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of clinicopathological features and LGR5 expression in colon adenocarcinoma.
    Sato K; Uehara T; Iwaya M; Nakajima T; Miyagawa Y; Suga T; Ota H; Tanaka E
    Ann Diagn Pathol; 2019 Jun; 40():161-165. PubMed ID: 31100646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of tumor budding in colorectal carcinoma: correlation with β-catenin nuclear expression.
    El-Gendi S; Al-Gendi A
    J Egypt Natl Canc Inst; 2011 Mar; 23(1):1-9. PubMed ID: 22099930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous expression of Lgr5 as a risk factor for focal invasion and distant metastasis of colorectal carcinoma.
    Zheng Z; Yu H; Huang Q; Wu H; Fu Y; Shi J; Wang T; Fan X
    Oncotarget; 2018 Jul; 9(53):30025-30033. PubMed ID: 30046385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of stem cell markers CD44 and Lgr5 in colorectal cancer and its relationship with lymph node and liver metastasis].
    Wang XF; Zhang XL; Xu LP; Shi GG; Zheng HY; Sun BC
    Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(36):2899-2904. PubMed ID: 30293346
    [No Abstract]   [Full Text] [Related]  

  • 15. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
    J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lgr5 is a potential marker of colorectal carcinoma stem cells that correlates with patient survival.
    Wu XS; Xi HQ; Chen L
    World J Surg Oncol; 2012 Nov; 10():244. PubMed ID: 23153436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of doublecortin-like kinase 1 and leucine-rich repeat-containing G-protein-coupled receptor 5 in patients with stage II/III colorectal cancer: Cancer progression and prognosis.
    Kang XL; He LR; Chen YL; Wang SB
    World J Gastroenterol; 2020 Nov; 26(43):6853-6866. PubMed ID: 33268966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer.
    Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K
    Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Most colitis associated carcinomas lack expression of LGR5: a preliminary study with implications for unique pathways of carcinogenesis compared to sporadic colorectal carcinoma.
    Iwaya M; Ota H; Nakajima T; Uehara T; Riddell R; Conner J
    BMC Cancer; 2021 Feb; 21(1):119. PubMed ID: 33541282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 in colorectal cancer.
    Uchida H; Yamazaki K; Fukuma M; Yamada T; Hayashida T; Hasegawa H; Kitajima M; Kitagawa Y; Sakamoto M
    Cancer Sci; 2010 Jul; 101(7):1731-7. PubMed ID: 20384634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.